A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Clinical trial NCT06978647 · RECRUITING

Trial details

NCT number: NCT06978647
Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Antiphospholipid Syndrome (APS)Rheumatoid Arthritis (RA)IgG4-Related Diseases Sjogren's Syndrome

Start date: 2025-05-19
Primary completion: 2026-05-19
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.